Abstract
Linezolid is currently indicated to treat vancomycin-resistant Enterococcus faecium infections, nosocomial pneumonia caused by Staphylococcus aureus or Streptococcus pneumoniae, complicated and uncomplicated skin and skin structure infections, and community-acquired pneumonia. We report a case of linezolid-induced lactic acidosis during treatment of vancomycin-resistant enterococcal bacteremia after mitral valve replacement and permanent pacemaker implantation. We also review the current literature describing other cases of linezolid-associated hyperlactatemia.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wiener, M., Guo, Y., Patel, G. et al. Lactic Acidosis after Treatment with Linezolid. Infection 35, 278–281 (2007). https://doi.org/10.1007/s15010-007-6302-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-007-6302-x